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ABSTRACT 
Previous studies have reported that oleuropein, the major constituent of olive leaves, has car-
dioprotective effects. There is no report related to oleuropein and ischemic-reperfusion inju-
ries (cardiac dysfunction and myocardial infarction) as well as preconditioning in rat hearts. 
56 male Wistar rats were divided into 7 groups (n=8). Group 1 as the control group and 
groups 2 to 7 as the treatment groups that received a single dose of oleuropein (100 mg/kg, 
i.p.) 1, 3, 6, 12, 24 and 48 hours before the excision of the heart, respectively. After these 
times, their hearts were excised and subjected to 30 min regional ischemia and 120 min reper-
fusion under Langendorff apparatus. Electrocardiogram and intraventricular pressures were 
monitored and recorded throughout the procedure. Finally, infarct size was measured by tri-
phenyltetrazolium chloride staining.  
Compared to the control group, oleuropein significantly reduced infarct size and reperfusion-
induced cardiac dysfunction in groups 2 and 3. Oleuropein markedly attenuated both ischemic 
and reperfusion arrhythmias in groups 2 and 3. There was no significant difference between 
other groups (4 to 7) than the control group. Heart rate had no significant difference among all 
of the groups.  
These results indicate that pretreatment of rats with a single dose of intraperitoneal oleuropein 
could protect their heart against ischemic-reperfusion injury for at least 3 hours. However, it 
has no preconditioning effect, since oleuropein had not cardioprotective effects 24 hour later. 
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INTRODUCTION 
Oleuropein, the main constituent of ol-
ive leaves, is a phenolic complex that has 
many biological roles, including hypoli-
pidemic (Jemai et al., 2008), hypoglycemic 
(Al-Azzawie and Alhamdani, 2006), anti-
inflammatory (Puel et al., 2006), anti-
ischemic (Andreadou et al., 2006), anti-
atherosclerotic (Coni et al., 2000), antimi-
crobial (Zhao et al., 2009; Jiang et al., 
2008; Zanichelli et al., 2005) and antidia-
betic (Al-Azzawie and Alhamdani, 2006; 
Jemai et al., 2009) properties. Most studies 
have attributed these activities to its antiox-
idant activity. However, the results of some 
studies have shown that oleuropein can also 
affect intracellular signaling pathways (Sato 
et al., 2007; Santiago-Mora et al., 2011). 
Oleuropein and its metabolite, hydroxytyro-
sol, have a number of pharmacological 
properties against cardiovascular disorders 
(Singh et al., 2008). In 1978, Petkov and 
Manolov reported that intravenous admin-
istration of a single dose of oleuropein 
(10-40 mg/kg) has antiarrhythmic effect 
against barium chloride induced-arrhythmia 
in rabbits. Also, it had antiarrhythmic ef-
fects opposed to calcium chloride and aco-
nitine induced-arrhythmia in rats (Petkov 
and Manolov, 1978). In 2004, Manna and 
his colleagues (Manna et al., 2004) for the 
first time, using isolated rat heart model, 
showed the experimental evidence of cardi-
oprotective effect of oleuropein (20 µg/g 
wet weight through perfusion fluid for 15 
min before global ischemia) against acute 
ischemic-reperfusion injury. In 2006, An-
dreadou and his co-workers (2006) demon-
strated anti-ischemic effect of oleuropein 
(10 or 20 mg/kg orally for 3 weeks) in rab-
bits that was evident with reduced infarct 
size and oxidative stress. In 2007, An-
dreadou et al. reported that intraperitoneal 
administration of 100 and 200 mg/kg 
oleuropein two days before injection of a 
toxic dose of doxorubicin (20 mg/kg, i.p, 
once time), attenuated doxorubicin-induced 
cardiotoxicity in rats. This protective effect 
was evident with reduced oxidative stress 
and inhibition of lipid peroxidation. There 
was not any significant difference between 
doses of 100 and 200 mg of oleuropein 
(Andreadou et al., 2007). 
In this study, we wanted to know 
whether the intraperitoneal administration 
of a single dose of oleuropein (100 mg/kg) 
has cardioprotective and preconditioning 
effects against ischemic and reperfusion 
arrhythmia and dysfunction in isolated rat 
hearts. Preconditioning is a phenomenon 
thereby short period(s) of a sublethal stimu-
lus like ischemia, or pharmacological 
agents like nitroglycerin, before a pro-
longed lethal ischemia renders that organ 
more resistance to ischemic-reperfusion in-
jury (Murry et al., 1986; Baharvand et al., 
2010). Preconditioning is a biphasic mode 
with an early phase that initiates immedi-
ately after the stimulus and lasts for 1-3 h 
followed by a late phase that starts 12-24 h 
later and continues about 24- 48 h (Bahar-
vand et al., 2010). 
 
MATERIALS AND METHODS 
Animals  
Male Wistar rats, weighing 250–300 g 
(8-12 weeks of age) obtained from Pasture 
Institute (Tehran, Iran), were housed under 
standard condition with 22±2 oC, 55 % hu-
midity and 12 light/dark cycle. All animals 
were supplied with a standard laboratory 
diet and tap water ad libitum. This study 
was confirmed by the Animal Ethic Com-
mittee of Shahid Sadoughi University of 
Medical Sciences, Yazd, Iran. 
 
Heart isolation  
Rats were anaesthetized with sodium 
thiopental (60 mg/kg, i.p.) and heparinized 
by injection of 1000 IU intraperitoneally. 
Then, the hearts were excised and aorta 
cannulated to perfuse retrogradly under 
Langendorff apparatus with filtered Krebs 
solution. It contains NaCl 118 mM, KCl 
4.7 mM, CaCl2 2.5 mM, MgSo4 1.2 mM, 
Glucose 10 mM, NaHco3 25 mM and 
KH2Po4 1.2 Mm gassed with 95 % O2 and 
5 % Co2. The perfusion pressure was main-
tained at 70-80 mmHg. Next, a water filled 
balloon was inserted into the left ventricle 
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to monitor intraventricular pressure through 
Narko pressure transducer connected to the 
powerlab data acquisition system (Lab chart 
6, ADIstrument, Australia). The hearts were 
warmed by a water filled jacket. After-
wards, coronary flow was collected and 
measured at certain time points. Any heart 
with systolic pressure less than 80 mmHg 
or severe disrrhythmia was excluded.  
 
Ischemic-reperfusion injury 
A 5-0 silk suture was passed around the 
left anterior descending coronary artery 
(LAD). After 20 min stabilization to induce 
ischemia, both ends of the thread were 
passed through a polyethylene tube and 
held tightly in place with a small clip for 
30 min. Then, the LAD was reoccluded to 
reperfuse the ischemic area for 120 min. 
 
Measurement of infarct size  
At the end of reperfusion, the thread 
was tightened again and the hearts were 
perfused by 1 % Evans Blue to separate is-
chemic and non-ischemic areas. Then, the 
heart was freezed and cut into 2 mm slices. 
Next, the slices were stained with triphenyl-
tetrazolium chloride (TTC) that shows the 
viable cells as red and the infarcted cells as 
white color. The slices were photographed 
and the infarct size area was determined by 
Image Tool software. Finally, infarct size 
was expressed as percentage of ischemic 
area.  
 
Assessment of ischemic and reperfusion 
arrhythmia 
Electrocardiogram (ECG) was moni-
tored by placing two electrodes on the right 
atrium and the apex of the hearts. Arrhyth-
mia were monitored during ischemia and 
reperfusion and analyzed separately accord-
ing to the Lambeth conventions (Walker et 
al., 1988): ventricular ectopic beats (VEBs) 
as a wide premature QRS complex without 
P wave, ventricular tachycardia (VT) as a 
run of four or more VEBs and ventricular 
fibrillation (VF) was considered as a signal 
in which the individual QRS complex can 
no longer be distinguishable. Complex 
forms (bigenimy and salvos) were added to 
VEB counts as well as their episodes. In 
addition, severity of arrhythmia was quanti-
fied by a scoring system (Pourkhalili et al., 
2009) in which VEBs alone were given 
score of 1, bigenimy/salvos score of 2, ven-
tricular tachycardia score of 3, ventricular 
fibrillation score of 4, SVF (ventricular fi-
brillation lasting more than 120 seconds) 
score of 5. The allocated number was the 
most severe type of arrhythmia observed in 
that heart.  
 
Experimental groups 
56 rats were divided into 7 groups as 
follows (Table 1): Group 1, rats were given 
1 ml 5 % dextrose (vehicle) and their hearts 
were only subjected to 30 min ischemia and 
120 min reperfusion Group 2 to 7, rats were 
given oleuropein (100 mg/kg, i.p.) 1, 3, 6, 
12, 24 and 48 h before their hearts subject-
ed to 30 min ischemia and 120 min reperfu-
sion under Langendorff apparatus. This 
dose was chosen according to the previous 
studies on heart (Andreadou et al., 2007) 
which did not have any significant effect on 
systolic and diastolic pressure in anesthe-
tized rats in our pilot study (data not 
shown). Andreadou et al. have shown that 
intraperitoneal administration of 100 and 
200 mg/kg oleuropein 2 days before intra-
peritoneal administration of doxorubicin 
could attenuate doxorubicin-induced car-
diotoxicity and there was not any difference 
between the cardioprotective effects of the-
se doses. As previously noted, we wanted to 
know whether this dose of oleuropein 
(100 mg/kg, i.p) has cardioprotective and 
preconditioning like effects independent of 
the changes in hemodynamic parameters. 
So, we chose only a single dose of oleuro-
pein before ischemia to induce precondi-
tioning. 
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Table1: The experimental groups 
 
Groups Substance Delayed times 
Regional 
Ischemia Reperfusion 
Control  Dextrose 5 %  30 min 120 min 
O1 Oleuropein (100 mg/kg, i.p.) 1 h 30 min 120 min 
O3 Oleuropein (100 mg/kg, i.p.) 3 h 30 min 120 min 
O6 Oleuropein (100 mg/kg, i.p.) 6 h 30 min 120 min 
O12 Oleuropein (100 mg/kg, i.p.) 12 h 30 min 120 min 
O24 Oleuropein (100 mg/kg, i.p.) 24 h 30 min 120 min 
O48 Oleuropein (100 mg/kg, i.p.) 48 h 30 min 120 min 
 
 
 
Statistics  
Data were shown as Mean ± SEM or 
the percentage of incidence. Heart rate 
(HR), left ventricular end diastolic pressure 
(LVEDP), left ventricular developed pres-
sure (LVDP) and coronary flow (CF) were 
analyzed by two–way ANOVA repeated 
measure test with time as one variable and 
treatment as another variable. Infarct size, 
VEBs episodes, VT and VF numbers and 
durations were analyzed by one-way 
ANOVA with Tukey test as post hoc test. 
The incidence of VT and VF were ana-
lyzed by Fisher Exact test. The scores of 
arrhythmia were analyzed by non-
parametric Kraskul-Wallis test. Finally, P 
values less than 0.05 were considered to be 
statistically significant. 
 
RESULTS 
Hemodynamic parameters 
These parameters, including heart rate, 
LVEDP, left ventricular end systolic pres-
sure (LVESP), LVDP and CF, were moni-
tored during baseline, at the end of 30 min 
ischemia and every 30 min during reperfu-
sion. As Table 2 shows, although the heart 
rate reduced significantly during the ische-
mic and reperfusion procedure, there was 
not any significant difference among all 
groups. LVEDP had not any marked dif-
ference between groups at baseline time, 
however, it was increased slightly during 
ischemia with no significancy in all 
groups. During reperfusion, LVEDP was 
increased severely in all groups. In com-
parison to the control (Con) group, LVEDP 
was increased with less severity in groups 
O1 and O3. LVESP had not any consider-
able difference at baseline and ischemic 
times among groups. But it was signifi-
cantly increased during reperfusion which 
was significantly higher in O1 and O3 
groups than the Con group. Similarly, 
LVDP was decreased markedly during is-
chemia and increased again during reperfu-
sion. But LVDP was significantly higher in 
O1 and O3 groups than the Con group dur-
ing reperfusion. CF has been considerably 
decreased during ischemia and increased 
again during reperfusion. Although, these 
data show that CF is higher in O1 and O3 
groups, there was only a significant differ-
ence between O1 and Con groups. 
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Table 2: Hemodynamic parameters  
 
Variables Baseline Ischemia Reperfusion 
15 min (30 min) 30 min 60 min 90 min 120 min 
HR (Beats/min)       
   Con 247 ± 14 238 ± 13 231 ± 11 222 ± 11 215 ± 11 209 ± 10 
   O1 257 ± 15 245 ± 10 239 ± 14 233 ± 13 228 ± 12 220 ±   9 
   O3 252 ± 12 242 ±   9 236 ± 11 227 ± 11 221 ± 11 217 ± 11 
   O6 266 ± 14 242 ± 10 227 ±   9 218 ±   9  212 ±   8b 209 ±   8 
   O12 247 ± 13 242 ±   9 240 ± 10 237 ±   9 231 ±   9 216 ±   9 
   O24 252 ± 11 251 ±   9 248 ±   9 235 ±   7 223 ±   8 213 ±   8 
   048   254 ± 15   247 ± 13   241 ± 10   235 ± 11   226 ± 11   214 ± 10 
LVEDP(mmHg)       
   Con 5.2 ± 0.3 9.4 ± 1.5 16.0 ± 2.4 16.8 ± 2.5 17.8 ± 2.0 18.4 ± 0.9 
   O1 6.5 ± 0.7 8.2 ± 1.0 10.8 ± 0.8b 11.7 ± 1.4b 11.7 ± 1.3c 11.3 ± 1.3c 
   O3 6.0 ± 0.7 7.1 ± 0.6   9.3 ± 0.9c 10.2 ± 1.0c 11.7 ± 1.1c 12.6 ± 0.9c 
   O6 5.8 ± 0.7 8.0 ± 0.8 13.5 ± 0.7 15.6 ± 1.2 16.0 ± 1.4 16.8 ± 1.1 
   O12 6.0 ± 0.7 7.8 ± 0.6 14.3 ± 0.9 16.6 ± 1.2 18.3 ± 1.4 19.7 ± 1.7 
   O24 6.3 ± 0.8 8.1 ± 0.6 15.0 ± 1.0 17.2 ± 1.0 18.7 ± 0.7 19.3 ± 1.1 
   O48 6.8 ± 0.8 9.3 ± 0.9 15.1 ± 0.8 16.8 ± 0.9 17.8 ± 0.7 18.8 ± 0.4 
LVESP(mmHg)       
    Con 122 ± 5.2 71 ± 6.2 83 ± 1.8 62 ± 5.9 61 ± 4.1 58 ± 5.2 
    O1 117 ± 6.1 68 ± 6.1 99 ± 5.4 93 ± 4.7c 85 ± 4.5b 80 ± 5.2a 
    O3 122 ± 3.9 79 ± 5.2 104 ± 3.8a 95 ± 2.8c 85 ± 1.9b 77 ± 2.3a 
    O6 119 ± 4.6 71 ± 5.5 87 ± 1.9 74 ± 3.57 63 ± 3.3 58 ± 2.8 
    O12 113 ± 7.0 73 ± 6.9 88 ± 6.3 73 ± 3.8 67 ± 3.8 57 ± 3.4 
    O24 115 ± 7.9 70 ± 8.8 81 ± 4.8 69 ± 5.9 63 ± 6.2 60 ± 5.7 
    O48 113 ± 4.8 65 ± 4.7 84 ± 3.8 67 ± 4.6 58 ± 4.6 54 ± 3.2 
LVDP(mmHg)       
      Con 119 ± 5.9 69 ± 9.3 67 ± 3.7 52 ± 6.7 43 ± 5.8 41 ± 6.4 
   O1 111 ± 5.6 60 ± 6.1 102 ± 4.2c 92 ± 3.5c 85 ± 2.9c 81 ± 3.7c 
   O3 118 ± 4.4 75 ± 5.2 96 ± 4.0c 87 ± 3.1c 78 ± 2.8c 70 ± 3.1b 
   O6 114 ± 5.2    63 ± 6.0 73 ± 2.3 58 ± 4.3 48 ± 3.6 42 ± 3.1 
  O12 107 ± 6.5 63 ± 6.4 74 ± 6.2 57 ± 4.1 49 ± 3.63 40 ± 3.6 
  O24 110 ± 8.1 62 ± 9.3 66 ± 5.1 52 ± 5.9 45 ± 6.7 42 ± 7.1 
   O48 107 ± 5.1 56 ± 5.3 69 ± 4.1 51 ± 4.5 40 ± 4.6 35 ± 3.1 
CF(mmHg)       
  Con 11.5 ± 1.1 5.6 ± 0.8 7.4 ± 0.5 5.9 ± 0.6 5.2 ± 0.7 5.0 ± 0.6 
  O1 10.4 ± 0.6 5.3 ± 0.4 9.7 ± 0.7 9.3 ± 0.6b 8.1 ± 0.7a 8.0 ± 0.7b 
  O3 10.1 ± 0.8 5.6 ± 1.0 9.0 ± 0.6 8.3 ± 0.7a 7.4 ± 0.5 6.9 ± 0.5 
  O6 11.2 ± 0.9 6.0 ± 0.7 8.1 ± 0.8 6.5 ± 0.6 5.5 ± 0.5 4.7 ± 0.4 
  O12 11.0 ± 0.7 5.9 ± 0.5 7.8 ± 0.6 6.5 ± 0.6 5.6 ± 0.6 4.7 ± 0.5 
  O24 10.3 ± 0.7 5.7 ± 0.4 7.6 ± 0.4 6.0 ± 0.4 5.1 ± 0.5 4.3 ± 0.4 
  O48 10.5 ± 0.6 5.8 ± 0.5 7.1 ± 0.4 6.2 ± 0.5 5.4 ± 0.5 4.8 ± 0.5 
 
Data were indicated as Mean ± SEM 
HR = heart rate; LVEDP = left ventricular end diastolic pressure; LVESP = left ventricular end systolic 
pressure; LVDP = left ventricular developed pressure; CF = coronary flow  
a = P<0.05; b = P<0.01; c = P<0.001 compared to Con group 
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Ischemic-induced arrhythmia 
Figure 1 shows the episodes of VEBs, 
the incidence percentages of VT and VF 
and the scores of arrhythmia during 30 min 
regional ischemia. The episodes of VEBs 
were decreased significantly from 391 ± 57 
in the Con to 171 ± 25 and 179 ± 24 in O1 
and O3 groups, respectively. There was not 
any marked difference between O6 (281 ± 
24), O12 (329 ± 30), O24 (369 ± 42) and 
O48 (345 ± 45) groups than the Con group 
(Figure 1A). The incidence of VT% was 
decreased significantly from 100 % in the 
Con group to 50 and 62.5 % in O1 and O3 
groups, respectively. The incidence of 
VT% was 87.5, 100, 100 and 100 % in O6, 
O12, O24 and O48 groups, respectively 
(Figure 1B). VF% was 62.5 % in Con 
group and decreased significantly to 0 and 
37.5 % in O1 and O3 groups, respectively. 
There was not any considerable different 
between the incidence of VF in O6 (50 %), 
O12 (50 %), O24 (50 %) and O48 (62.5 %) 
groups (Figure 1C). Similarly, the score 
number of ischemic arrhythmia was only 
significantly decreased in O1 (2.25 ±0.25) 
and O3 (2.37 ± 0.26) than Con group (3.75 
± 0.25). It was 3.2 ± 0.31, 3.2 ± 0.25, 3.6 ± 
0.18 and 3.7 ± 0.16 in O6, O12, O24 and 
O48 groups, respectively (Figure 1D). 
 
 
Figure 1: Effect of intraperitoneal administration of a single dose of oleuropein on the magnitude of 
ischemic arrhythmia in isolated rat hearts at different times following the administration of oleuropein. 
VEB, ventricular ectopic beat; VT, ventricular tachycardia; VF, ventricular fibrillation; Con, control 
group and O1, O3, O6, O12, O24 and O48 means rats were pretreated with a single dose of intraperi-
toneal oleuropein (100 mg/kg, i.p.) 1, 3, 6, 12, 24 and 48 before excision of the heart. b = P<0.01 and c 
= P<0.001 compared to con group.  
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Table 3 indicates that there was only a sig-
nificant difference in VT and VF numbers 
and duration between O1 and O3 groups 
compared to the Con group. 
 
Reperfusion-induced arrhythmias  
Figure 2 presents the episodes of 
VEBs, the incidence percentage of VT and 
VF and the arrhythmia scores during 
120 min reperfusion following 30 min re-
gional ischemia. VEBs episodes were 
markedly decreased in O1 (193 ± 27) and 
O3 (207 ± 26) compared to the Con group 
(400 ± 32). There was not any significant 
difference between other groups and the 
Con group. It was 434 ± 76, 460 ± 67, 497 
± 75, and 454 ± 81 in O6, O12, O24 and 
O48 groups, respectively (Figure 2A). The 
incidence percentage of VT also signifi-
cantly decreased in O1 (50 %) and O3 
(62.5 %) groups compared to the Con 
group (100%) and it was occurred in all 
hearts of O6, O12, O24 and O48 groups 
(Figure 2B). The incidence of VF was con-
siderably deceased in O1 (0 %), O3 
(25 %), O6 (50 %) and O12 (50 %) groups 
compared to the Con group. The incidence 
of VF was 62.5 % in O24 group and 
62.5 % in O48 group (Figure 2C). Figure 
2D shows that the score of arrhythmia was 
only decreased significantly in O1 group 
(2.37 ± 0.32) than the Con group (3.62 ± 
0.18). It was 2.75 ± 0.32 in O3, 3.50 ± 0.19 
in O6, 3.37 ± 0.26 in O12, 3.50 ± 0.26 in 
O24 and 3.62 ± 0.18 in O48 groups, re-
spectively. 
 
 
 
 
Figure 2: Effect of intraperitoneal administration of a single dose of oleuropein on the magnitude of 
reperfusion arrhythmia in isolated rat hearts at different times following the administration of oleuro-
pein. VEB, ventricular ectopic beat; VT, ventricular tachycardia; VF, ventricular fibrillation; Con, control 
group and O1, O3, O6, O12, O24 and O48 means rats were pretreated with a single dose of intraperi-
toneal oleuropein (100 mg/kg, i.p.) 1, 3, 6, 12, 24 and 48 before excision of the heart. a = P<0.05 and c 
= P<0.001 compared to con group. 
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Table 3: Effect of intraperitoneal administration of a single dose of oleuropein on the ventricular tachy-
cardia and ventricular fibrillation numbers and durations during 30 min regional ischemia in isolated rat 
hearts 
 
Groups Ventricular tachycardia Ventricular fibrillation  
Number Duration(s) Numbers Duration(s) 
Con 17.6 ± 3.4 41.1 ± 8.5 1.87 ± 0.7 12.3 ± 5.3 
O1 2.8 ± 1.2a 6.20 ± 2.4a    0b    0b 
O3 3.6 ± 1.2a 8.37 ± 2.8a 0.25 ± 0.2a 2.62 ± 1.3a 
O6 12.0 ± 3.2 28.1 ± 9.7 1.37 ± 0.6 11.1 ± 4.8 
O12 15.1 ± 3.7 34.3 ± 7.8 1.25 ± 0.6 10.0 ± 4.7 
O24 13.0 ± 2.9 42.3 ± 8.8 1.50 ± 0.5 9.12 ± 3.7 
O48 16.5 ± 2.4 38.4 ± 8.7 1.52 ± 0.5 9.12 ± 3.6 
Data shown as Mean ± SEM 
S = second; Con = control group and O1, O3, O6, O12, O24 and O48 means rats were pretreated with 
a single dose of intraperitoneal oleuropein (100 mg/kg, i.p.) 1, 3, 6, 12, 24 and 48 before excision of 
the heart. a = P<0.05 and b = P<0.01 compared to Con group 
 
 
 
Table 4 shows the VT and VF numbers 
and durations during 120 min reperfusion. 
Compared to the Con group, they were on-
ly significantly reduced in O1 and O3 
groups. 
 
 
 
Table 4: Effect of intraperitoneal administration of a single dose of oleuropein on the ventricular tachy-
cardia and ventricular fibrillation numbers and durations during 120 min reperfusion following 30 min 
regional ischemia in isolated rat hearts 
 
Groups Ischemia Reperfusion 
Numbers Duration(s) Number Duration(s) 
Con 30.7 ± 5.7 53.9 ± 11.4   1.5 ± 0.5 14.6 ± 4.0 
O1 3.40 ± 1.3a   5.0 ± 2.5a         0b         0b 
O3 3.00 ± 1.0a 11.5 ± 3.4a 0.25 ± 0.16a 2.52 ± 1.3a 
O6 22.2 ± 5.2 36.5 ± 10.3 1.25 ± 0.6 11.1 ± 4.8 
O12 38.0 ± 11 61.8 ± 17.6 1.37 ± 0.6 10.0 ± 4.7 
O24 31.5 ± 7.9 54.9 ± 16.8 1.25 ± 0.5 12.1 ± 4.9 
O48 28.8 ± 9.0 45.7 ± 12 1.62 ± 0.7 12.5 ± 5.1 
Data shown as Mean ± SEM 
s = second; Con = control group and O1, O3, O6, O12, O24 and O48 means rats were pretreated with 
a single dose of intraperitoneal oleuropein (100 mg/kg, i.p.) 1, 3, 6, 12, 24 and 48 before excision of 
the heart. a = P<0.05 and b = P<0.01 compared to Con group 
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Infarct size assessment  
The same as VF and VT incidence per-
centages, the mean of the infarct size was 
significantly decreased in O1 and O3 
groups compared to the Con group (45.6 ± 
4). The infarct size was 17.8 ± 2.9, 20.1 ± 
2.4, 34.6 ± 3.1, 39.9 ± 3, 42.7 ± 3.2 and 
40.1 ± 4.1 in O1, O3, O6, O12, O24 and 
O48 groups, respectively (Figure 3). 
 
 
 
 
 
Figure 3: Effect of intraperitoneal administra-
tion of a single dose of oleuropein on the myo-
cardial infarct size induced by 30 min regional 
ischemia and 120 min reperfusion in isolated rat 
hearts at different times following the admin-
istration of oleuropein. Con, control group and 
O1, O3, O6, O12, O24 and O48 means rats 
were pretreated with a single dose of intraperi-
toneal oleuropein (100 mg/kg, i.p.) 1, 3, 6, 12, 
24 and 48 before excision of the heart.  
c = P<0.001 compared to con group 
 
DISCUSSION 
The main findings of this study show 
that the intraperitoneal administration of a 
single dose of oleuropein (100 mg/kg) has a 
cardioprotective, but not preconditioning 
effect against ischemic-reperfusion injury 
in isolated rat heart for about three hours. 
This protective effect was evident with re-
duced infarct size, diminished the magni-
tude of ischemic and reperfusion arrhyth-
mia and improved cardiac dysfunction. 
Acute coronary syndromes as a conse-
quence of ischemic injuries to the myocar-
dium are still responsible for a large propor-
tion of all hospital administrations and all 
causes of death around the world (Williams 
and Benjamin, 2000; Hausenloy and 
Yellon, 2007; Huikuri et al., 2001; Misra et 
al., 2009). The malignant arrhythmia, in-
cluding VT and VF, are still the major 
complications during acute phase of myo-
cardial infarction (Kaneko et al., 2009). 
Although the relief of related ischemia by 
coronary artery bypass graft (CABG) could 
reduce the incidence of arrhythmia, it seems 
that CABG itself exerts effects on arrhyth-
miogenic substrates (Wu et al., 2003). It 
appears many factors involve in the initia-
tion of arrhythmia, but the main factor is 
the deficiency of the myocardial defense 
system (Wu et al., 2003). It has been sug-
gested that the generation of a large quanti-
ty of free radicals plays an important role in 
the establishment of ischemic and reperfu-
sion arrhythmia. Hence, administration of 
free radical scavengers has antiarrhythmic 
effects (Somova et al., 2004). Since the 
heart has low regenerative ability (Moloja-
vyi et al., 2001), increasing the antioxidant 
defense system of the myocardium has a 
great relevance. In this study, we wanted to 
know whether the intraperitoneal admin-
istration of a single dose of oleuropein 
would have cardioprotective and precondi-
tioning-like effects in isolated rat hearts. If 
so, how long does it take? Preconditioning 
is a phenomenon thereby short period(s) of 
sublethal ischemia or administration of a 
single dose of some drugs make the heart 
more tolerant against the subsequent pro-
longed ischemia (Murry et al., 1986; Ba-
harvand et al., 2010). Preconditioning has 
two phases: early and delayed phases. The 
early phase, initiates immediately after the 
insertion of the stimulus and ends 3 hours 
later, is caused by post-translation of pro-
teins. The delayed phase starts 12-24 hours 
following the insertion of the stimulus and 
continues up to about 72 hours later, is re-
lated to the gene expression (Baharvand et 
al., 2010). Epidemiological data have indi-
cated that the lower incidence of cardiovas-
cular diseases and cancers in Mediterranean 
area is associated with high consumption of 
natural phenolic antioxidants, especially 
oleuropein, through their traditional diet 
(Waterman and Lockwood, 2007). Oleuro-
pein is the main constituent of olive leaf 
extracts that has anti-inflammatory (Puel et 
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al., 2004), antidiabetic (Al-Azzawie and 
Alhamdani, 2006; Jemai et al., 2009), anti-
atherosclerosis (Coni et al., 2000; Visioli 
and Galli, 1994), antimicrobial (Tranter et 
al., 1993; Fleming et al., 1973) and anti-
tumoral (Hamdi and Castellon, 2005) ef-
fects. Although most studies have attributed 
these effects to the antioxidant property of 
oleuropein (Coni et al., 2000; Visioli and 
Galli, 1994; Kruk et al., 2005), some stud-
ies also reported that oleuropein could 
change intracellular signaling pathway 
(Sato et al., 2007; Santiago-Mora et al., 
2011). Our data showed that intraperitoneal 
administration of a single dose of oleuro-
pein had anti-ischemic effects that were ev-
ident with reduced malignant VT and VF 
arrhythmia during ischemia and reperfu-
sion, reduced infarct size and improved 
cardiac dysfunctions during reperfusion. 
This study showed that a single dose of 
oleuropein also has a cardioprotective effect 
that is consistent with Petkov and Mano-
lov’s work. They reported that the intrave-
nous administration of a single dose of 
oleuropein (40 mg/kg) reduced the magni-
tude of calcium chloride and aconitine-
induced arrhythmia in anaesthetized rats. 
They also addressed that this dose of 
oleuropein had a hypotensive effect in cats 
and dogs, but not in rabbits, as a dose de-
pendent manner (Petkov & Manolov, 
1978). But in our study, oleuropein (100 
mg/kg) had not any effect on blood pressure 
before isolation of the heart, and on the 
baseline coronary flow under Langendorff 
apparatus, which may be due to the manner 
of oleuropein injection. On the other hand, 
we injected 40 mg/kg oleuropein into the 
tail vein of three anaesthetized rats for 
1 minute. We observed that blood pressure 
reduced immediately following oleuropein 
injection and rapidly return to baseline val-
ues (data not shown). We do not have any 
explanation for this transient hypotensive 
effect. There are a few studies about 
oleuropein and heart. Andreadou et al. 
(2007) reported that pretreatment of rats 
with 100 and 200 mg/kg intraperitoneal 
oleuropein doses for two days attenuated 
the doxorubicin-induced cardiotoxicity 
through its antioxidant activity. The differ-
ence between these doses was not statisti-
cally significant. In our study, only one 
dose of 100 mg/kg oleuropein was adminis-
tered that its cardioprotective effects last for 
3 hours. It seems these effects are related to 
its antioxidant activity and it does not seem 
oleuropein altered the intracellular signal-
ing pathways. During ischemia and reperfu-
sion, the generation of oxygen free radicals 
increase in very high quantities that the an-
tioxidant defense mechanism of the heart 
could not scavenge them (Krematinos, 
2008). Hence, it seems that oleuropein in 
our study has increased the antioxidant ac-
tivity of the myocardium. There are two 
other studies about cardioprotective effect 
of oleuropein, which are different from our 
study. Manna et al. (2004) using isolated rat 
heart model reported that perfusing the iso-
lated rat hearts, with 50 µg/g wet weight of 
oleuropein for 15 min before global ische-
mia, had anti-ischemic and antioxidant ef-
fects. They have not reported any effect re-
lated to arrhythmia and cardiac dysfunc-
tions. Andreadou et al. (2006) indicated the 
anti-infarct and anti-ischemic effects of 
oleuropein in anesthetized rabbit heart 
model. In their study, rabbits were pretreat-
ed orally with 10-20 mg/kg oleuropein for 3 
weeks which was different with the design 
of our study. These two studies concluded 
that oleuropein exerted its effects via its 
antioxidant property (Andreadou et al., 
2006; Manna et al., 2004). On the other 
hand, it appears that oleuropein could not 
precondition the heart against lethal ische-
mia. Because it was not observed two phas-
es of cardioprotection which is seen in pre-
conditioning phenomenon: early and de-
layed phases (Andreadou et al., 2006; 
Hausenloy and Yellon, 2008; Luh and 
Yang, 2006; Murry et al., 1986). Also, 
some data show that oleuropein could 
change the intracellular pathways, especial-
ly the expression of some genes (Sato et al., 
2007; Santiago-Mora et al., 2011). Then, 
further studies need to determine the effect 
of oleuropein in another animal species 
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with different models. Another important 
point of our study is that all of the cardio-
protective effects of a single dose of intra-
peritoneal oleuropein stopped 6 hours later. 
It appears that the plasma concentration of 
oleuropein decreased below the level of its 
cardioprotective dose. Previous studies re-
ported that following its absorption from 
the gastrointestinal tract, oleuropein rapidly 
distributed throughout the body and metab-
olized mainly in the conjugated forms and 
then excreted in the urine (Jemai et al., 
2008; Luh and Yang, 2006; Bazoti et al., 
2010). In this study, we did not measure the 
plasma concentration of oleuropein, hence 
further in vivo studies need to be deter-
mined; 1) How does the plasma concentra-
tion of oleuropein change in various times 
following its administration? 2) How long 
do the cardioprotective effects of oleuro-
pein last for? And 3) Whether oleuropein 
has cardiac preconditioning in in vivo mod-
els?  
In summary, our study emphasizes that 
a single dose of intraperitoneal administra-
tion of oleuropein (100 mg/kg) has anti-
infarct, antistunning and antiarrhythmic, but 
no preconditioning effects in rat hearts. 
Hence, it is likely that future studies could 
prove the beneficial effects of oleuropein in 
managing of coronary heart disease, ische-
mic-reperfusion injuries and cardiac sur-
gery in human beings. 
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